1. Acknowledgement to Referees

   Acknowledgement to Referees 12 November 2018 Pages: 1085 - 1088

2. The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials

   • Ya Luo
   • Kai Lu
   • Xiaoli Zhou

   Systematic Review 25 September 2018 Pages: 1089 - 1108

   

3. Cardiovascular Toxicities with Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors in Cancer Patients: A Meta-Analysis of 77 Randomized Controlled Trials

   • Jing Li
   • Jian Gu

   Systematic Review 16 October 2018 Pages: 1109 - 1123

   

4. Replacement Effects and Budget Impacts of Insurance Coverage for Sodium-Glucose Co-Transporter-2 Inhibitors on Oral Antidiabetic Drug Utilization

   • Hsiang-Yin Chen
   • Pei-Yin Chiu
   • Jason C. Hsu

   Original Research Article 15 September 2018 Pages: 1125 - 1133

   

5. Multicenter, Open-Label Study of Long-Term Topiroxostat (FYX-051) Administration in Japanese Hyperuricemic Patients with or Without Gout

   • Tatsuo Hosoya
   • Tomohiko Ishikawa
   • Tetsuo Ohashi

   Original Research Article Open access 15 September 2018 Pages: 1135 - 1143

   

6. Bioequivalence and Pharmacokinetics of Bisoprolol–Amlodipine 5 mg/5 mg Combination Tablet versus Bisoprolol 5 mg Tablet and Amlodipine 5 mg Tablet: An Open-Label, Randomized, Two-Sequence Crossover Study in Healthy Chinese Subjects

   • Chaoying Hu
   • Xiao Hu
   • Lan Zhang

   Original Research Article 19 September 2018 Pages: 1145 - 1154

   

7. Cost-utility of Sunitinib Versus Pazopanib in Metastatic Renal Cell Carcinoma in Canada using Real-world Evidence

   • Sara Nazha
   • Simon Tanguay
   • Alice Dragomir

   Original Research Article 28 September 2018 Pages: 1155 - 1165

   

8. Economic Evaluations of Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia in Middle- and High-Income Countries: A Systematic Review

   • Jie Fu
   • Yuchen Liu
   • Bin Wu

   Original Research Article 19 September 2018 Pages: 1167 - 1178

   

9. Signal Detection Between Fluoroquinolone Use and the Risk of Rhegmatogenous Retinal Detachment: Sequence Symmetry Analysis Using Nationwide South Korean Healthcare Database Between 2004 and 2015

   • Yeon-Hee Baek
   • Sang Jun Park
   • Ju-Young Shin

   Original Research Article 01 October 2018 Pages: 1179 - 1188

   

10. Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study Findings

    • Hiroki Koshimichi
    • Toru Ishibashi
    • Toshihiro Wajima

    Original Research Article Open access 04 October 2018 Pages: 1189 - 1196

    

11. Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database

    • Philippe Picaut

    Letter to the Editor Open access 03 November 2018 Pages: 1197 - 1198

12. Response to “Comment on: Botulinum Toxin Type A Overdoses: Analysis of the FDA Adverse Event Reporting System Database”

    • Rashid Kazerooni
    • Edward P. Armstrong

    Letter to the Editor 03 November 2018 Pages: 1199 - 1200